ロード中...

Overview of FDA’s Expanded Access Program for Investigational Drugs

Expanded access, also called “compassionate use,” provides a pathway for patients to gain access to investigational drugs, biologics, and medical devices used to diagnose, monitor, or treat patients with serious diseases or conditions for which there are no comparable or satisfactory therapy options...

詳細記述

保存先:
書誌詳細
出版年:Ther Innov Regul Sci
主要な著者: Jarow, Jonathan P., Lurie, Peter, Ikenberry, Sarah Crowley, Lemery, Steven
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5443564/
https://ncbi.nlm.nih.gov/pubmed/28553565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2168479017694850
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!